Milton S. Hershey Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Milton S. Hershey Medical Center sits in the top decile of US sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count).

396 total trials 55 currently recruiting 255 completed early-phase tilt top decile by trial count

Milton S. Hershey Medical Center: 396 sponsored US clinical trials, 55 recruiting.

Milton S. Hershey Medical Center sponsors 396 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 255 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Child Abuse, with 4 trials.

Top-decile sponsor footprint

Milton S. Hershey Medical Center ranks in the top decile of sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

255 of 320 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

396 total, page 1 of 8

RECRUITING Phase 2

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

NCT07321912

RECRUITING NA

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

NCT07649876

RECRUITING NA

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

NCT07454460

RECRUITING Phase 1

CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

NCT07016971

RECRUITING NA

Ultrasound (US) Guided External Ventricular Catheter Placement

NCT06253858

RECRUITING Phase 1

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199

RECRUITING NA

Little Cigar Oxidants

NCT06310187

RECRUITING NA

The Impact of Yoga on Endometriosis-Related Pain

NCT06559852

RECRUITING Phase 2

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

NCT06926595

RECRUITING Phase 4

Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants

NCT06871488

RECRUITING NA

Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

NCT07237607

RECRUITING NA

Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Students

NCT07240792

RECRUITING NA

Adapting Exposure for Adolescent AN

NCT07188155

RECRUITING NA

Activating SilverSneakers Benefits for Seniors With Osteoarthritis

NCT06782347

RECRUITING NA

Stories to Prevent (StoP) HPV Cancers

NCT06808776

RECRUITING NA

Closed Loop and Education for Hypoglycemia Awareness Restoration

NCT06325202

RECRUITING Phase 1

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

NCT06600698

RECRUITING Phase 2

Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance

NCT06396247

RECRUITING

Utility of the Superior Vena Cava Collapsibility Index (SVC-CI) to Predict Fluid Responsiveness in Patients With Coronary Artery Disease Undergoing Surgical Revascularization

NCT06645327

RECRUITING NA

Transitional Care Program for Fluid Overload in Cirrhosis

NCT06174272

RECRUITING Early Phase 1

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

NCT06482853

RECRUITING Phase 2

GLP-1R Agonist Treatment for Opioid Use Disorder

NCT06548490

RECRUITING Phase 1

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

NCT06541262

RECRUITING

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

NCT06401577

RECRUITING NA

Use of Nicotine Pouches Among Daily Smokers

NCT06043362

RECRUITING NA

A Fruit and Vegetable Prescription Program

NCT06107816

RECRUITING

Digital Assessment of Speech and Fine Motor Control in ALS

NCT06315673

RECRUITING NA

Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)

NCT05998629

RECRUITING NA

Feasibility of a Mindfulness Intervention for Endometriosis Surgery

NCT06141720

RECRUITING NA

Exposure Therapy Study In Adults With Eating Disorders

NCT06171711

RECRUITING NA

Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

NCT03921944

RECRUITING NA

iLookOut Micro-learning to Improve Knowledge Retention

NCT06273618

RECRUITING NA

iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention

NCT04324619

RECRUITING Early Phase 1

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

NCT06281756

RECRUITING NA

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

NCT06195943

RECRUITING NA

Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders

NCT06085092

RECRUITING NA

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

NCT05092022

RECRUITING NA

Effects of Head-of-Bed on Intracranial Pressure

NCT05604404

RECRUITING

Pain and Disability Outcomes in Post Amputation Patients

NCT05716321

RECRUITING NA

Treatment for Problematic Sexual Behavior of Preteen Children

NCT05514730

RECRUITING Early Phase 1

Angiotensin-(1-7) Cardiovascular Effects in Aging

NCT05301192

RECRUITING Phase 2

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

NCT04414514

RECRUITING NA

NASH AMPK Exercise Dosing (AMPED) Trial

NCT04987879

RECRUITING NA

Diabetes Clinical Decision Support

NCT05447806

RECRUITING NA

Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations

NCT04612738

RECRUITING

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

NCT05197920

RECRUITING NA

Continuous Glucose Monitoring in At-Risk Newborns

NCT04386005

RECRUITING NA

Effect of Music on Pain and Anxiety in Chronic Pain Patients Undergoing Lumbar Interventional Procedures.

NCT04924244

RECRUITING NA

The Venous Distension Reflex and Orthostatic Hypertension

NCT03496792

RECRUITING

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

NCT05937594

Page 1 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 33
Phase 3 25
Phase 4 21

What is open in the Milton S. Hershey Medical Center pipeline

55 recruiting of 396 indexed (14% open); 255 completed (64%).

Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).

Top condition: Child Abuse (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Milton S. Hershey Medical Center: open-pipeline peers nationwide

Peers matched on 396 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%12%14%16%18%20% Total trials Recruiting share Milton S. Hershey Medical CenterAbramson Cancer Center at Penn MedicineCase Comprehensive Cancer CenterUniversity of NebraskaTakedaUniversity of CincinnatiJohns Hopkins Bloomberg School of Public HealthBeiGeneSeattle Institute for Biomedical and Clinical Research
Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 396 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Milton S. Hershey Medical Center page

396 registered trials is a research-attention snapshot, not an endorsement of Milton S. Hershey Medical Center or any single study.

  • 55 of Milton S. Hershey Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Child Abuse is the condition Milton S. Hershey Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Child Abuse trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Milton S. Hershey Medical Center pipeline card: 396 registered trials from official public datasets.Report a data error.